Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 11.47M
March 31, 2026 8.156M
December 31, 2025 10.62M
September 30, 2025 12.44M
June 30, 2025 15.62M
March 31, 2025 19.06M
December 31, 2024 24.96M
September 30, 2024 8.936M
June 30, 2024 18.69M
March 31, 2024 18.17M
December 31, 2023 22.68M
September 30, 2023 27.04M
June 30, 2023 30.47M
March 31, 2023 35.06M
December 31, 2022 39.37M
September 30, 2022 43.78M
June 30, 2022 48.07M
March 31, 2022 51.42M
December 31, 2021 55.48M
September 30, 2021 59.99M
June 30, 2021 44.38M
March 31, 2021 48.85M
December 31, 2020 19.99M
September 30, 2020 25.21M
June 30, 2020 28.20M
Date Value
March 31, 2020 32.07M
December 31, 2019 23.67M
September 30, 2019 6.005M
June 30, 2019 8.58M
March 31, 2019 11.34M
December 31, 2018 17.92M
September 30, 2018 23.14M
June 30, 2018 30.20M
March 31, 2018 8.615M
December 31, 2017 4.979M
September 30, 2017 8.802M
June 30, 2017 16.10M
March 31, 2017 16.55M
December 31, 2016 23.23M
September 30, 2016 28.09M
June 30, 2016 16.20M
March 31, 2016 19.64M
December 31, 2015 23.44M
September 30, 2015 25.97M
June 30, 2015 27.74M
March 31, 2015 36.71M
December 31, 2014 47.34M
September 30, 2014 62.27M
June 30, 2014 74.57M
March 31, 2014 89.72M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics